Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation
1 other identifier
observational
51
1 country
1
Brief Summary
This study will examine the performance of the Persona assays in identifying the time when risk of pregnancy is highest by comparing results to ultrasound observed ovulation and other indices of ovulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2013
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedFirst Posted
Study publicly available on registry
March 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedDecember 2, 2014
November 1, 2014
9 months
January 29, 2013
November 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ultrasound
Accuracy of the LH urine assay contained within PERSONA at predicting ovulation, by comparing the day of the LH surge with ultrasound observed ovulation
Participants will be followed for one menstrual cycle, anticipated average of four weeks.
Secondary Outcomes (2)
Quantitative determination of urinary and serum levels of LH and E3G
Participants will be followed one menstrual cycle, an anticipated four weeks
Volunteer recorded BBT and cervical secretion observations.
Participants will be followed for one menstrual cycle, an anticipated four weeks
Eligibility Criteria
General Public
You may qualify if:
- Female
- Aged 18 - 40 years
- Menstrual cycle length between 23 and 35 days
- Had two natural cycles prior to study participation
- Using non-hormonal contraception to avoid pregnancy OR abstaining from intercourse for the last three months and the present cycle
- N.B: Non hormonal contraception includes barrier methods such as male and female condoms, diaphragms or caps, non-hormonal intra-uterine devices such as coils, male and female sterilisation or natural family planning
You may not qualify if:
- Unwilling to provide written informed consent to participate in the study or comply with study procedures
- Pregnant
- Breastfeeding
- Has menopausal symptoms such as night sweats or hot flushes
- Using any hormonal treatments e.g. hormonal contraception, fertility treatments and hormone replacement therapy (except thyroxin)
- Taking antibiotics (based on decision by principle investigator)
- Has a diagnosis of polycystic ovarian syndrome (PCOS)
- Has impaired liver or kidney function
- Intending to use PERSONA as a contraceptive during the study period
- Contraindications to frequent blood sampling e.g. anaemia, hypotonia and blood clotting diseases
- Contraindications to frequent ultrasound examinations e.g. morbid obesity and recent abdominal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Green-ivf, Rheydter Strasse 143, Grevenboich
Düsseldorf, 41515, Germany
Related Publications (2)
Gnoth C, Roos J, Broomhead D, Schiffner J, Godehardt E, Freundl G, Johnson S. Antimullerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation day. Fertil Steril. 2015 Dec;104(6):1535-43.e1-4. doi: 10.1016/j.fertnstert.2015.08.027. Epub 2015 Sep 15.
PMID: 26384163DERIVEDJohnson S, Weddell S, Godbert S, Freundl G, Roos J, Gnoth C. Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day. Clin Chem Lab Med. 2015 Jun;53(7):1099-108. doi: 10.1515/cclm-2014-1087.
PMID: 25720077DERIVED
Biospecimen
Urine samples Serum samples
Study Officials
- PRINCIPAL INVESTIGATOR
Christian Gnoth, Dr
Green-ivf, Rheydter Strasse 143
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2013
First Posted
March 1, 2013
Study Start
February 1, 2013
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
December 2, 2014
Record last verified: 2014-11